Envisioning the Future: Medicine in the Year 2050

Abstract Despite massive advances in basic knowledge, technology, and availability of medical and biological data during the past few decades, transformational breakthroughs in medicine have yet to be seen, and yet, a bright future where medicine is can be imagined, in Leroy Hood's memorable formulation, “personalized, predictive, preventative, and participatory.” How will we get to that bright future? As a thought experiment, how a drug for rheumatoid arthritis may be discovered 25 years from now can be imagined in detail, and the additional breakthroughs in technology and processes that will occur in the subsequent decade leading to the mid-century mark can be further speculated. Of course all such predictions are inevitably wrong; but the aim of such prognostication is to stimulate fresh thinking about what must happen for that desired future state to come into existence. Accordingly, the specific and significant changes that must occur across every aspect of the process, ranging from the technologies ...

[1]  Fredric Cohen,et al.  Macro trends in pharmaceutical innovation , 2005, Nature Reviews Drug Discovery.

[2]  A. Hopkins,et al.  The druggable genome , 2002, Nature Reviews Drug Discovery.

[3]  J. DiMasi,et al.  Pharmaceutical Innovation in the 21st Century: New Drug Approvals in the First Decade, 2000–2009 , 2011, Clinical pharmacology and therapeutics.

[4]  J. DiMasi,et al.  Competitiveness in follow-on drug R&D: a race or imitation? , 2011, Nature Reviews Drug Discovery.

[5]  Richard W Peck Driving earlier clinical attrition: if you want to find the needle, burn down the haystack. Considerations for biomarker development. , 2007, Drug discovery today.

[6]  Bruce L. Booth,et al.  Opinion: Prospects for productivity , 2004, Nature Reviews Drug Discovery.

[7]  L. Hood,et al.  Systems medicine: the future of medical genomics and healthcare , 2009, Genome Medicine.

[8]  John P. Overington,et al.  How many drug targets are there? , 2006, Nature Reviews Drug Discovery.

[9]  J. Garnier,et al.  Rebuilding the R&D engine in big pharma. , 2008, Harvard business review.

[10]  Peter Schwartz,et al.  The Art of the Long View: Planning for the Future in an Uncertain World , 1996 .

[11]  S. Inayatullah Six pillars: futures thinking for transforming , 2008 .

[12]  Charles C. Persinger,et al.  How to improve R&D productivity: the pharmaceutical industry's grand challenge , 2010, Nature Reviews Drug Discovery.

[13]  F. Goodsaid,et al.  The Critical Path Institute's Approach to Precompetitive Sharing and Advancing Regulatory Science , 2010, Clinical pharmacology and therapeutics.

[14]  Craig M. Crews,et al.  Targeting the undruggable proteome: the small molecules of my dreams. , 2010, Chemistry & biology.

[15]  I. Kola,et al.  Can the pharmaceutical industry reduce attrition rates? , 2004, Nature Reviews Drug Discovery.

[16]  I. Kola,et al.  The State of Innovation in Drug Development , 2008, Clinical pharmacology and therapeutics.

[17]  T. Wirth,et al.  15-Lipoxygenase-1 induces lipid peroxidation and apoptosis, and improves survival in rat malignant glioma. , 2012, In vivo.